Interleukin 6 upregulates MCL-1 expression by a JAK/STAT3 pathway in cholangiocarcinoma cells

被引：0
|
作者：
Isomoto, H [1 ]
Kobayashi, S [1 ]
Werneburg, N [1 ]
Bronk, S [1 ]
Gores, G [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：261A / 262A
页数：2
相关论文
共 50 条
  • [31] Curculigoside upregulates BMAL1 to decrease nucleus pulposus cell apoptosis by inhibiting the JAK/STAT3 pathway
    Lei, Linchuan
    Wang, Hua
    Zhao, Zhuoyang
    Huang, Yuming
    Huang, Xiaohui
    Guo, Xingyu
    Jiang, Guowei
    Chen, Shunlun
    Wang, Wantao
    Chen, Xi
    Zheng, Zhaomin
    Wang, Jianru
    Chen, Fan
    OSTEOARTHRITIS AND CARTILAGE, 2025, 33 (04) : 412 - 425
  • [32] IL-6 up-regulates Mcl-1 in human myeloma cells through JAK/STAT rather than Ras/MAP kinase pathway
    Puthier, D
    Bataille, R
    Amiot, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (12) : 3945 - 3950
  • [33] IL-6 upregulates the expression of IL-6R through the JAK2/STAT3 signalling pathway to promote progression of hepatocellular carcinoma
    Song, Li
    Xu, Ruyue
    Cai, Wenpeng
    Liang, Jiaojiao
    Cao, Niandie
    Gao, Jiafeng
    Tang, Xiaolong
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2023, 98 (01)
  • [34] Study on expression of IL-6/JAK/STAT3 signaling pathway in category IIIB prostatitis
    Li, Guangyu
    Lan, Haiyan
    Liang, Jihong
    Xian, Jing
    Fang, Dan
    Mo, Yuncong
    Zheng, Cheng
    Dong, Yingjin
    Li, Yuanfa
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3779 - 3785
  • [35] Interleukin 6 decreases p27kiP1 by upregulating SKP2 through a STAT3 pathway in human extrahepatic cholangiocarcinoma cells
    Byun, Sun Jeoung
    Kim, Young Jin
    Kim, Hong Joo
    Park, Dong Il
    CANCER RESEARCH, 2009, 69
  • [36] Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3
    Kim, Nam-Hoon
    Lee, Mun-Yong
    Park, Seon-Joo
    Choi, Jeong-Sun
    Oh, Mi-Kyung
    Kim, In-Sook
    IMMUNOLOGY, 2007, 122 (04) : 607 - 614
  • [37] Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway
    Zhang, Hao-Xuan
    Fan, Rui
    Chen, Qian-En
    Zhang, Lin -Jun
    Hui, Yang
    Xu, Peng
    Li, Si -Yang
    Chen, Guang-Ying
    Chen, Wen-Hao
    Shen, Dong-Yan
    HELIYON, 2024, 10 (05)
  • [38] LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCARCINOMA CELLS FROM CYTOTOXICITY VIA A STAT-3-INDEPENDENT, Mcl-1 ACTIVATION
    Cadamuro, M.
    Morton, S. D.
    Brivio, S.
    Stecca, T.
    Massani, M.
    Bassi, N.
    Floreani, A.
    Strazzabosco, M.
    Fabris, L.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S90 - S90
  • [39] LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCARCINOMA CELLS FROM CYTOTOXICITY VIA A STAT-3-INDEPENDENT, MCL-1 ACTIVATION
    Morton, S. D.
    Cadamuro, M.
    Brivio, S.
    Stecca, T.
    Massani, M.
    Bassi, N.
    Floreani, A.
    Strazzabosco, M.
    Fabris, L.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E65 - E65
  • [40] Epidermal growth factor upregulates endometrial CYR61 expression via activation of the JAK2/STAT3 pathway
    Klein, Rebecca
    Stiller, Simone
    Gashaw, Isabella
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2012, 24 (03) : 482 - 489
12345